Ropes & Gray has advised Verastem Oncology. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Verastem Oncology (Nasdaq: VSTM) has announced the...
Verastem Oncology Prices $90 Million Public Offering
Spyre Therapeutics Completes $316 Million Public Offering
Ropes & Gray has advised Spyre Therapeutics. Covington & Burling LLP has advised the underwriters. Spyre Therapeutics, Inc., a clinical-stage biotechnology company, has concluded a public...
Zenas BioPharma’s $120 Million PIPE Transaction
Ropes & Gray has advised Zenas BioPharma. Zenas BioPharma has received a Private Investment in Public Equity (PIPE) transaction expected to result in gross proceeds of...
CAMP4 Secures Up to $100 Million Through Private Placement to Fund SYNGAP1 Clinical Program
Ropes & Gray has advised CAMP4 Therapeutics on the transaction, and Mintz has advised the placement agents. CAMP4 Therapeutics Corporation has announced a private placement transaction...
Rhythm Pharmaceuticals Announces $201 Million Public Equity Offering
Ropes & Gray has advised the underwriters. Latham & Watkins has advised Rhythm Pharmaceuticals, Inc. Lando & Anastasi served as intellectual property counsel for the company....
Sanofi Invests up to $25 Million in Adagene SAFEbody Antibody Program
Ropes & Gray has advised Sanofi. Davis Polk & Wardwell and Walkers (Hong Kong) have advised Adagene Inc. Sanofi has announced a strategic investment of up...
Insmed Completes $750 Million Follow-On Public Offering
Covington & Burling has advised Insmed Inc. on the offering, Hunton Andrew Kurth served as Virginia counsel and Cooley as intellectual property counsel to the company,...
Sionna Therapeutics’ $219.2 Million Upsized IPO
Goodwin Procter advised Sionna Therapeutics, Inc., and Ropes & Gray advised the underwriters in the offering. Sionna Therapeutics (Nasdaq: SION) (Sionna) announced its initial public offering...
Zai Lab’s $200 Million Secondary Offering
Ropes & Gray represented Zai Lab Limited in the offering, while Simpson Thacher & Bartlett represented the underwriters. Zai Lab Limited (“Zai Lab” or the “Company”)...
CAMP4 Therapeutics’ $75 Million IPO
Ropes & Gray represented CAMP4 Therapeutics in the transaction, and Paul Hastings represented the underwriters. CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company, announced...
Zenas BioPharma’s $225 Million IPO
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
Bicara Therapeutics’ $315 Million IPO
Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...